CALTX — Calliditas Therapeutics AB Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMid Cap
- SEK5.53bn
- SEK5.53bn
- SEK1.21bn
Annual cashflow statement for Calliditas Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -28 | -380 | -524 | -422 | -373 |
| Depreciation | |||||
| Non-Cash Items | 0.486 | 15.5 | 66.7 | 61.3 | 102 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -45.3 | 55.1 | -3.81 | 49.3 | -164 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -71 | -309 | -462 | -311 | -435 |
| Capital Expenditures | -16.2 | — | -22.7 | -2.51 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.89 | -173 | -1.69 | -2.63 | -13.7 |
| Acquisition of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -18.1 | -173 | -24.3 | -5.14 | -13.7 |
| Financing Cash Flow Items | -12.7 | -178 | -67.9 | -0.001 | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 199 | 769 | 435 | 576 | 200 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 107 | 243 | -40.8 | 294 | -275 |